AI assistant
Sending…
IMMUCELL CORP /DE/ — Director's Dealing 2013
Sep 17, 2013
34519_dirs_2013-09-17_b552e1bc-27c4-400f-bb95-f569a9208bef.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IMMUCELL CORP /DE/ (ICCC)
CIK: 0000811641
Period of Report: 2013-09-17
Reporting Person: ROTHSCHILD JONATHAN E (Director, 10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-09-17 | Common Stock, par value $0.10 per share | W | 39355 | — | Acquired | 504635 | Direct |
Footnotes
F1: This figure includes 214,655 shares of common stock held by Arterio Inc., a corporation owned soley by Mr. Rothschild
F2: This Form 4 is being filed to confirm the status of Mr. Rothschild as a co-executor of his parents' estate. He is a one-third beneficiary of that estate. The distribution of the assets of that estate has not yet been resolved.
More from IMMUCELL CORP /DE/
Regulatory Filings
2026
May 14
Annual Report
2026
May 13
Regulatory Filings
2026
May 8
Proxy Solicitation & Information Statement
2026
Apr 24
Regulatory Filings
2026
Apr 14
Regulatory Filings
2026
Apr 14
Regulatory Filings
2026
Apr 8
Annual Report
2026
Mar 30
Director's Dealing
2026
Mar 25
Director's Dealing
2026
Mar 23